US equities |
MU $1,029.00 ▼-0.66% NVDA $229.28 ▼-0.52% SPCX $162.57 ▲+1.25% TSLA $382.70 ▲+2.05% AAPL $336.64 ▼-1.11% MSFT $535.07 ▲+2.38% AMZN $262.43 ▲+3.29% META $718.67 ▼-0.31%
FinancialContent

Amgen (NQ:AMGN)

414.87 +7.43 (+1.82%)
Delayed Quote Updated: 4:00 PM EDT, Oct 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Amgen

< Previous 1 2 3 4 5 6 7 8 9
...
73 74 Next >
Friday's session: top gainers and losers in the dow jones index ↗
Via Chartmill
Top dow jones movers in Friday's session ↗
Via Chartmill
News headline image
A Stock Market Crash Is Coming By the End of 2027, According to Some Economists. Here Are 2 Stocks to Buy Before That Happens ↗
These companies might bend during a downturn, but they won’t break. 
Via The Motley Fool
Topics Economy Intellectual Property
Exploring the top movers within the dow jones index during today's session. ↗
Via Chartmill
These dow jones stocks are moving in today's session ↗
Via Chartmill
News headline image
Where Will Eli Lilly Stock Be in 5 Years? Follow the Pipeline Beyond Zepbound ↗
The company is far from a one-trick pony. 
Via The Motley Fool
Top dow jones movers in Wednesday's session ↗
Via Chartmill
Which dow jones stocks are moving on Wednesday? ↗
Via Chartmill
Wednesday's session: top gainers and losers in the S&P500 index ↗
Via Chartmill
Stay informed with the top movers within the dow jones index on Tuesday. ↗
Via Chartmill
Uncover the latest developments among dow jones stocks in today's session. ↗
Via Chartmill
News headline image
2 Nasdaq 100 Stocks Worth Investigating and 1 We Question
The Nasdaq 100 (^NDX) is home to some of the biggest success stories in tech and growth investing. However, certain stocks in the index face challenges like ... 
Via StockStory
Monday's session: top gainers and losers in the dow jones index ↗
Via Chartmill
News headline image
Amgen vs. Vertex Pharmaceuticals: Which Biotech Stock Is a Better Buy in 2026? ↗
One offers a more affordable entry point while the other boasts some of the highest profit margins in the sector. The choice comes down to whether you prioritize income stability or growth potential. 
Via The Motley Fool
Friday's session: top gainers and losers in the dow jones index ↗
Via Chartmill
What's going on in today's session: dow jones movers ↗
Via Chartmill
News headline image
3 Dow Jones Stocks with Exciting Potential
The biggest names in corporate America call the Dow Jones (^DJI) home, but only a handful are still growing at a strong pace. Some of these blue-chip stocks ... 
Via StockStory
Topics Stocks
These dow jones stocks are moving in today's session ↗
Via Chartmill
News headline image
2 Profitable Stocks with Exciting Potential and 1 We Find Risky
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does... 
Via StockStory
Which dow jones stocks are moving on Tuesday? ↗
Via Chartmill
Top dow jones movers in Monday's session ↗
Via Chartmill
Uncover the latest developments among dow jones stocks in today's session. ↗
Via Chartmill
News headline image
2 Healthcare Stocks That Just Delivered Great News for Investors ↗
And there could be more positive developments ahead. 
Via The Motley Fool
Exploring the top movers within the dow jones index during today's session. ↗
Via Chartmill
Friday's session: top gainers and losers in the dow jones index ↗
Via Chartmill
Stay informed with the top movers within the dow jones index on Thursday. ↗
Via Chartmill
News headline image
Winners And Losers Of Q2: Amgen (NASDAQ:AMGN) Vs The Rest Of The Therapeutics Stocks
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking a... 
Via StockStory
Topics Artificial Intelligence
News headline image
Viking's Obesity Edge May Be Staying Power, Not Weight Loss ↗
Viking Therapeutics shares jumped 36% after VK2735 maintenance data showed patients kept most weight loss on less frequent dosing, though Phase 3 results and commercial funding remain unresolved. 
Via MarketBeat
Stay informed with the top movers within the dow jones index on Wednesday. ↗
Via Chartmill
Tuesday's session: top gainers and losers in the dow jones index ↗
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9
...
73 74 Next >